| Effectiveness of specialized palliative care: a systematic review C Zimmermann, R Riechelmann, M Krzyzanowska, G Rodin, I Tannock Jama 299 (14), 1698-1709, 2008 | 588 | 2008 |
| Potential drug interactions and duplicate prescriptions among cancer patients RP Riechelmann, IF Tannock, L Wang, ED Saad, NA Taback, ... Journal of the National Cancer Institute 99 (8), 592-600, 2007 | 418 | 2007 |
| Cancer-related fatigue: a practical review MPO Campos, BJ Hassan, R Riechelmann, A Del Giglio Annals of Oncology 22 (6), 1273-1279, 2011 | 276 | 2011 |
| Potential for drug interactions in hospitalized cancer patients RP Riechelmann, F Moreira, Ò Smaletz, ED Saad Cancer chemotherapy and pharmacology 56, 286-290, 2005 | 212 | 2005 |
| Drug interactions in oncology: how common are they? RP Riechelmann, A Del Giglio Annals of oncology 20 (12), 1907-1912, 2009 | 206 | 2009 |
| Análise do atraso no diagnóstico e tratamento do câncer de mama em um hospital público DC Trufelli, VC Miranda, MBB Santos, NMP Fraile, PG Pecoroni, ... Revista da Associação Médica Brasileira 54, 72-76, 2008 | 164 | 2008 |
| Guarana (Paullinia cupana) Improves Fatigue in Breast Cancer Patients Undergoing Systemic Chemotherapy MP de Oliveira Campos, R Riechelmann, LC Martins, BJ Hassan, ... The Journal of Alternative and Complementary Medicine 17 (6), 505-512, 2011 | 162 | 2011 |
| Potential drug interactions in cancer patients receiving supportive care exclusively RP Riechelmann, C Zimmermann, SN Chin, L Wang, A O'Carroll, ... Journal of pain and symptom management 35 (5), 535-543, 2008 | 161 | 2008 |
| Symptom and medication profiles among cancer patients attending a palliative care clinic RP Riechelmann, MK Krzyzanowska, A O’Carroll, C Zimmermann Supportive Care in Cancer 15, 1407-1412, 2007 | 158 | 2007 |
| Phase II trial of mirtazapine for cancer-related cachexia and anorexia RP Riechelmann, D Burman, IF Tannock, G Rodin, C Zimmermann American Journal of Hospice and Palliative Medicine® 27 (2), 106-110, 2010 | 139 | 2010 |
| Adverse drug reactions and drug interactions as causes of hospital admission in oncology V Miranda, A Fede, M Nobuo, V Ayres, A Giglio, M Miranda, ... Journal of pain and symptom management 42 (3), 342-353, 2011 | 136 | 2011 |
| Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer RP Riechelmann, CA Townsley, SN Chin, GR Pond, JJ Knox Cancer 110 (6), 1307-1312, 2007 | 132 | 2007 |
| Cancer-related fatigue: a review MPO Campos, BJ Hassan, R Riechelmann, A Del Giglio Revista da Associacao Medica Brasileira 57, 211-219, 2011 | 125 | 2011 |
| Futile medication use in terminally ill cancer patients RP Riechelmann, MK Krzyzanowska, C Zimmermann Supportive care in cancer 17, 745-748, 2009 | 119 | 2009 |
| A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic … MH Kulke, P Ruszniewski, E Van Cutsem, C Lombard-Bohas, JW Valle, ... Annals of Oncology 28 (6), 1309-1315, 2017 | 114 | 2017 |
| Use of unnecessary medications by patients with advanced cancer: cross-sectional survey A Fede, M Miranda, D Antonangelo, L Trevizan, H Schaffhausser, ... Supportive Care in Cancer 19, 1313-1318, 2011 | 104 | 2011 |
| Carcinoid syndrome: update on the pathophysiology and treatment AC Rubin de Celis Ferrari, J Glasberg, RP Riechelmann Clinics 73, e490s, 2018 | 97 | 2018 |
| Fadiga relacionada ao câncer: uma revisão MPO Campos, BJ Hassan, R Riechelmann, A del Giglio Revista da Associação Médica Brasileira 57, 211-219, 2011 | 94 | 2011 |
| Phase 2 trial of metformin combined with 5-fluorouracil in patients with refractory metastatic colorectal cancer VC Miranda, MI Braghiroli, LD Faria, G Bariani, A Alex, JEB Neto, ... Clinical colorectal cancer 15 (4), 321-328. e1, 2016 | 83 | 2016 |
| Complications from carcinoid syndrome: review of the current evidence JM Mota, LG Sousa, RP Riechelmann Ecancermedicalscience 10, 2016 | 82 | 2016 |
